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Transient Alterations of Cutaneous Sensory Nerve
Function by Noninvasive Cryolipolysis
Lilit Garibyan1, Laura Cornelissen2, William Sipprell1, Joachim Pruessner1, Sarina Elmariah3, Tuan Luo3,
Ethan A. Lerner3, Yookyung Jung1, Conor Evans1, David Zurakowski2, Charles B. Berde2 and R. Rox Anderson1
Cryolipolysis is a noninvasive, skin cooling treatment for local fat reduction that causes prolonged hypoesthesia
over the treated area. We tested the hypothesis that cryolipolysis can attenuate nociception of a range of sensory
stimuli, including stimuli that evoke itch. The effects of cryolipolysis on sensory phenomena were evaluated by
quantitative sensory testing (QST) in 11 healthy subjects over a period of 56 days. Mechanical and thermal pain
thresholds were measured on treated and contralateral untreated (control) ﬂanks. Itch duration was evaluated
following histamine iontophoresis. Unmyelinated epidermal nerve ﬁber and myelinated dermal nerve ﬁber
densities were quantiﬁed in skin biopsies from six subjects. Cryolipolysis produced a marked decrease in
mechanical and thermal pain sensitivity. Hyposensitivity started between two to seven days after cryolipolysis
and persisted for at least thirty-ﬁve days post treatment. Skin biopsies revealed that cryolipolysis decreased
epidermal nerve ﬁber density, as well as dermal myelinated nerve ﬁber density, which persisted throughout the
study. In conclusion, cryolipolysis causes signiﬁcant and prolonged decreases in cutaneous sensitivity. Our data
suggest that controlled skin cooling to speciﬁcally target cutaneous nerve ﬁbers has the potential to be useful for
prolonged relief of cutaneous pain and might have a use as a research tool to isolate and study cutaneous itch-
sensing nerves in human skin.
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INTRODUCTION
Cryolipolyis is controlled deep cooling of the skin and
subcutaneous fat, which is used clinically for noninvasive
and selective reduction of subcutaneous fat (Manstein et al.,
2008; Nelson et al., 2009). Crystallization of cytoplasmic
lipids occurs in adipocytes at temperatures well above the
freezing point of water. This crystallization is hypothesized to
produce selective injury, stress, and apoptosis of adipocytes,
followed by panniculitis and gradual fat loss (Zelickson et al.,
2009). During treatment, metal plates cooled to a temperature
below 0 °C are applied to the skin for 60minutes. Prolonged
hypoesthesia in the treated area is a common side effect,
resolving 1–2 months after treatment. The mechanism for this
unexpected, prolonged hypoesthesia is unknown. In a case
study report, histology of biopsies taken from a single patient
after cryolipolysis treatment did not show inﬂammation or
necrosis of nerves (Coleman et al., 2009). A small sample-
sized human study using nonquantitative neurologic evalua-
tion noted modest, reversible changes in sensory function
occurring in 66% of the patients after treatment (Coleman
et al., 2009). These ﬁndings suggest that skin cooling alters
cutaneous sensory nerve function, but it does not address the
neurosensory pathways and mechanisms involved.
The aim of this study was to characterize the long-term
effects of a single cryolipolysis treatment to the ﬂank of healthy
subjects on cutaneous nerve ﬁber density and sensory
functions, including pain and itch, over a 56-day follow-up
period. Quantitative sensory tests (QSTs) assessed cutaneous
sensitivity to mechanical and thermal stimuli. Itch duration
after local histamine iontophoresis was also determined. Skin
biopsies were obtained from six subjects for quantitative
histopathologic analysis of myelinated and unmyelinated
cutaneous nerve ﬁbers. We hypothesized that myelinated
nerves may undergo preferential injury during cryolipolysis
because of their lipid-rich myelin sheath, followed by
decreased peripheral nerve function and gradual regeneration.
RESULTS
Participants
Figure 1 shows the experimental timeline. Six women (55%)
and 5 men (45%) participated in the study (N= 11). Mean age
was 37.6±8.4 years (range 27–53 years). Mean BMI was
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27.1± 2.0 kg/m2 (range 22.5–29.1 kg/m2). Four subjects
(36%) were randomized for right ﬂank treatment, and 7
subjects (64%) for left ﬂank treatment. All subjects tolerated
cryolipolysis treatment, sensory testing, and skin biopsy
without signiﬁcant adverse effects. Six subjects (55%)
reported mild to moderate pain in the treated area 10minutes
after treatment. At 48–72 hours post treatment, only 2 out of
11 subjects (18%) reported mild discomfort in the treated
area. At Day 7 post treatment, no subjects reported pain.
Effects of cryolipolysis on pain and sensory thresholds
Table 1 summarizes mechanical and thermal pain thresholds
for the Treated and Control sides at each time point.
Mechanical pain threshold (MPT) was signiﬁcantly higher
(i.e., cutaneous hyposensitivity occurred) when compared
with baseline threshold at 48–72hrs after cryolipolysis
treatment (Baseline: 13 g (7–44 g) vs 42–72hrs: 56 g (14–
127 g), Z=− 2.58, P=0.01). Mechanical pain hyposensitivity
was observed at each time point until Day 56 post treatment
(Table 1). There were no signiﬁcant changes from baseline
threshold at the Control site at any time point during the
follow-up period (Table 1).
Cold pain threshold (CPT) signiﬁcantly increased after
cryolipolysis treatment (Treated side: F6,430=11.38, Po0.01;
Figure 2d). Onset of cold pain hyposensitivity began at
48–72hrs after treatment [Baseline: 24.1 oC (21.3-26.9oC) vs.
42–72 hrs: 18.3 oC (15.5–21.1 °C); Po0.001]. Cold pain
hyposensitivity persisted until Day 35 and returned to
baseline sensitivity by the end of the study (Table 1). There
were no signiﬁcant changes in cold pain threshold at the
Control site at any time point during the follow-up period
(Control side: F6,430=0.41, P= 0.87; Figure 2c).
Heat pain threshold (HPT) was less affected by cryolipolysis
treatment than MPT and CPT. There were signiﬁcant increases
in HPT after cryolipolysis treatment at both Treated and
Control sides (Treated side: F6,430=2.86, P= 0.01; Control
side: F6,430= 2.14, P= 0.05). However, the magnitude of the
change from baseline was very small (o2 °C) for both Treated
and Control sides, and warrant caution in their clinical
interpretation (Table 1).
Table 2 summarizes mechanical and thermal detection
thresholds for the Treated and Control sides at each time
point. Vibration detection (VDT), warmth detection (WDT),
and cool detection (CDT) thresholds signiﬁcantly increased
after cryolipolysis treatment (Treated side: VDT: F6,882=
31.14, Po0.001; WDT: F6,581= 6.89, Po0.001; CDT:
F6,581= 10.89, Po0.001). There were no grossly signiﬁcant
changes in detection threshold at the Control site (Control
side: VDT: F6,882= 1.23, P=0.29; WDT: F6,581= 1.74,
P= 0.11; CDT: F6,581= 0.63, P= 0.70; Figure 2). Vibration
and warmth detection modalities were affected by cryolipo-
lysis treatment to the greatest degree, as shown by the rapid
onset and prolonged duration of hyposensitivity. Onset of
vibration, warmth, and cool detection hyposensitivity began
at 48–72 hrs after treatment [VDT: Baseline: 17.8 μm/sec
(12.4–23.2 μm/sec) vs. 42–72 hrs: 26.3 μm/sec (20.9-31.7 μm/
sec), Po0.001;WDT: Baseline: 34.7 °C (33.7–35.6 °C) vs 42–
72 hrs: 35.2 °C (33.7–35.6 °C), P= 0.01; CDT: Baseline:
29.5 °C (28.1–30.8 °C) vs 42–72 hrs: 26.2 °C (24.8–27.5 °C),
Po0.001]. Vibration detection hyposensitivity was main-
tained until Day 35 and returned to baseline sensitivity by
Day 56 (Figure 2f). Warmth detection hyposensitivity
persisted until Day 21 and returned to baseline sensitivity
by Day 35 (Figure 2h). Cold detection hyposensitivity
returned to baseline levels at Day 7. There were no signiﬁcant
changes from baseline for mechanical detection thresholds at
the Treated or Control Side during the study (Table 2).
Itch
Histamine iontophoresis evoked pruritus at the Treated and
Control sides in all subjects. In the Treated side, the mean itch
duration at baseline was 9.7 min (CI: 6.8–12.7 min). Itch
duration on the Treated side vs baseline reduced by
48–72 hours post treatment (P= 0.008), and it remained
attenuated until the end of the study (Day 14 P=0.003, Days
21, 35 and 56 Po0.001), but not compared with the control
side (Supplementary Figure S1 and Supplementary Table S1
online). No signiﬁcant changes were detected in mean or
peak itch intensity or duration between control and treated
side for any time point after histamine iontophoresis
(Supplementary Table S2 and S3 online).
Cryolipolysis
treatment
Baseline 48–72 hours Day 7 Day 14 Day 21 Day 35 Day 56 End
Vi
si
t
Te
st
Biopsy Biopsy Biopsy Biopsy
Test 3: Histopathologic analysis (skin biopsy)
Test 1: Mechanical and thermal sensory function
Test 2: Histamine-induced itch sensory function
Figure 1. Experimental timeline. Experiments were performed in the test order listed. Arrows indicate the time point at which each experiment was performed.
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Confocal imaging of cutaneous nerves
Six subjects underwent skin biopsy at baseline, 48–72 hrs,
and Days 21 and 56 post treatment for microscopic
quantitative analysis of unmyelinated, epidermal nerve ﬁber
density (ENF) and dermal myelinated nerve ﬁber density
(Table 3). Cryolipolysis signiﬁcantly reduced the density of
ENFs, starting 48–72 hours and becoming more prominent at
Days 21 and 56 post treatment (Figure 3a and Table 3).
Density of dermal myelinated ﬁbers was unchanged at 48–
72hrs, but it was signiﬁcantly reduced starting from Day 21 (a
56% decrease, Po0.001) compared with baseline (Figure 3b).
By Day 56 post treatment, some recovery was seen, but there
was still signiﬁcantly lower dermal myelinated nerve ﬁber
density than baseline (Figure 3b and Table 3).
DISCUSSION
It has been reported in the past that cryolipolysis induces
prolonged hypoesthesia in the treated area (Coleman et al.,
2009), but this study speciﬁed and quantiﬁed the modality,
magnitude, and duration of sensory losses caused by cryo-
lipolysis treatment. We also discovered that cryolipolysis
causes prolonged reduction in the density of both myelinated
and unmyelinated cutaneous nerves, with myelinated nerve
ﬁbers in the dermis being the most greatly affected.
A single cryolipolysis treatment signiﬁcantly reduced pain
sensitivity to mechanical and thermal modalities within 48–
72 hrs post treatment. Mechanical and thermal hyposensitivity
persisted for at least 21 days. There was signiﬁcant loss of
unmyelinated epidermal and myelinated dermal nerve ﬁbers
Table 1. Mechanical and thermal pain thresholds over the control and cryolipolysis treated areas, and pairwise
comparisons for (1) side-tested and (2) post-treatment time1
Pairwise Comparisons
Side Time
QST Time Control Treatment Tx vs. Control Control: vs BL Tx: vs. BL
MPT (g)2
Baseline 36 (11–57) 13 (7–44) 0.11 (Z:–1.60) — —
48–72 h 26 (9–73) 56 (14–127) 0.033 (Z:–2.23) 0.68 (Z:–0.42) 0.013 (Z–2.58)
Day 7 30 (9–46) 32 (9–103) 0.09 (Z:–1.68) 0.59 (Z:–0.53) 0.053 (Z:–1.89)
Day 14 22 (7–73) 26 (11–180) 0.053 (Z:–1.99) 0.88 (Z:–0.15) 0.023 (Z:–2.29)
Day 21 34 (10–73) 45 (8–180) 0.06 (Z:–1.89) 0.51 (Z:–0.66) 0.033 (Z:–2.23)
Day 35 37 (12–100) 49 (17–127) 0.31 (Z:–1.00) 0.21 (Z:–1.25) 0.013 (Z: –2.58)
Day 56 30 (13–87) 45 (17–60) 0.80 (Z:–0.26) 0.37 (Z:–0.89) 0.023 (Z:–2.29)
CPT (oC)3
Baseline 22.9 (20.1–25.8) 24.1 (21.3–26.9) 0.27 – –
48–72 h 22.1 (19.3–25.0) 18.3 (15.5–21.1) o0.0013 0.46 o0.0013
Day 7 23 (20.1–25.8) 20.5 (17.6–23.3) 0.0263 0.97 0.0013
Day 14 21.8 (19.0–24.6) 18.2 (15.3–21.0) o0.0013 0.30 o0.0013
Day 21 21.8 (19.0–24.6) 17.4 (14.6–20.3) o0.0013 0.30 o0.0013
Day 35 22 (19.1–24.8) 21.5 (18.7–24.3) 0.68 0.37 0.0163
Day 56 22.1(19.2–24.9) 22.9 (20.1–25.8) 0.43 0.43 0.27
HPT (oC)3
Baseline 40.9 (39.4–42.4) 42.1 (40.6–43.6) 0.0353 – –
48–72 h 42.1 (40.6–43.5) 43 (41.5–44.5) 0.10 0.0473 0.12
Day 7 41.6 (40.1–43.1) 43 (41.5–44.5) 0.0143 0.26 0.12
Day 14 42 (40.5–43.4) 43.5 (42.0–45.0) 0.0073 0.07 0.0173
Day 21 42.8 (41.3–44.3) 44 (42.5–45.5) 0.0353 0.0013 0.0013
Day 35 41.9 (40.4–43.4) 42.1(40.6–43.6) 0.71 0.08 0.98
Day 56 42.3 (40.8–43.8) 42.8 (41.3–44.3) 0.46 0.0133 0.23
Abbreviations: BL, Baseline; CPT, Cold Pain Threshold; HPT, Heat Pain Threshold; MPT, Mechanical Pain Threshold; QST, Quantitative Sensory Testing;
Tx, Treatment.
Mean (95% Conﬁdence Interval); P-values determined from mixed model repeated-measures ANOVA with Bonferroni correction (assuming signiﬁcance at
Po0.05). We observed that for some QST measures, the differences were very small (i.e., o2oC) despite showing statistical signiﬁcance.
1Mechanical, cold, and heat pain are transmitted by myelinated Aδ and unmyelinated C ﬁbers (Backonja et al., 2013).
2Median (25th to 75th percentile); P-values determined from Wilcoxon Signed Ranks Test.
3Indicates statistically signiﬁcant differences.
Bold values denote signiﬁcant values.
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starting several days after cryolipolysis, which then recovered
gradually, but did not return to baseline during this study.
Dermal myelinated nerve ﬁbers were particularly affected,
which is consistent with our hypothesis that cryolipolysis
preferentially affects lipid-rich structures, including the myelin
sheath (Morell and Quarles, 1999). Myelinated nerve ﬁbers in
the dermis are composed of the larger, thickly myelinated
A-beta ﬁbers that transmit innocuous tactile and vibrational
stimuli, and smaller, thinly myelinated A-delta ﬁbers that
transmit cold perception, rapid heat, and noxious mechanical
stimuli (Provitera et al., 2007). The profoundly reduced
mechanosensation to both tactile and vibratory stimuli
following cryolipolysis is consistent with the loss of
myelinated A-beta ﬁbers. Although acute pain is transmitted
primarily by C and A-delta ﬁbers, many types of chronic pain
are characterized by allodynia, pain to light touch, and there
is an ongoing controversy about the degree to which different
types of allodynia involve large myelinated ﬁbers versus small
unmyelinated ﬁber terminals in the dorsal horn of the spinal
cord (Janig, 2011; Nagi et al., 2011). Myelinated A-delta ﬁbers
also have a role in itch sensation (Ringkamp et al., 2011).
Studies have shown that large myelinated ﬁbers are
most vulnerable to cold injury, which is supported by our
study ﬁndings (Irwin, 1996; Jia and Pollock, 1997, 1998). An
unexpected ﬁnding in our study is the decrease in unmyeli-
nated epidermal nerve ﬁber density after cryolipolysis
treatment, which can also contribute to reduction in pain
sensation. On the basis of only one patient, a previous report
found no changes in epidermal nerve ﬁber density at 6 weeks
after cryolipolysis treatment (Coleman et al., 2009). In
contrast, we analyzed multiple biopsies from six subjects,
using a rigorous approach with thick sections (70 μm) for
double immunostaining, and high-resolution confocal ima-
ging every 2 μm for the entire thickness, to allow 3D visuali-
zation of individual nerve ﬁbers for quantiﬁcation (Figures 3
and 4). In animals, low temperatures for long exposure times
can damage unmyelinated nerve ﬁbers (Jia and Pollock,
1998). The mechanisms by which cryolipolysis affects
unmyelinated nerve ﬁbers may be multifactorial, such as
cold-induced lipid crystallization, ischemia–reperfusion
injury, metabolic stress, or stress signaling pathways. We
could not further analyze the speciﬁc nerve ﬁber loss,
because of limited biopsy tissue in this human study.
There was gradual but excellent recovery of all cutaneous
sensations by 56 days after cryolipolysis, with the exception of
histamine-induced itch duration and MPT. However, cuta-
neous nerve ﬁber density had not fully recovered. Similarly,
ENF density has been reported to lag behind the complete
recovery of sensory function after high-dose capsaicin
treatment (Kennedy et al., 2010).
Histamine iontophoresis is widely used to study experi-
mental itch (Magerl et al., 1990; Ward et al., 1996; Ikoma
200 200
150 150
**
*
* *
*
*
*
* *
*
*
*
******
***
***
***
** ****
**
100 100
50 50
0
30
25
20
15
10
30
25
20
15
10
10
0
20
30
40
50
10
0
20
30
40
50
+
0
Control (white) Treatment (gray)
BL BL
48
–7
2 h
ou
rs
48
–7
2 h
ou
rs
Da
y7
Da
y7
Da
y 1
4
Da
y 1
4
Da
y 2
1
Da
y 2
1
Da
y 3
5
Da
y 3
5
Da
y 5
6
Da
y 5
6
BL
48
–7
2 h
ou
rs
Da
y 7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6
BL
48
–7
2 h
ou
rs
Da
y7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6BL
34
32
30
36
38
40
34
32
30
36
38
40
48
–7
2 h
ou
rs
Da
y7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6
BL
48
–7
2 h
ou
rs
Da
y 7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6 BL
48
–7
2 h
ou
rs
Da
y 7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6
BL
48
–7
2 h
ou
rs
Da
y7
Da
y 1
4
Da
y 2
1
Da
y 3
5
Da
y 5
6
Time (after treatment) Time (after treatment)
Time (after treatment)
Time (after treatment)Time (after treatment)
Time (after treatment) Time (after treatment)
Time (after treatment)
M
ec
ha
ni
ca
l p
ai
n 
th
re
sh
ol
d 
(g)
Co
ld
 p
ai
n 
th
re
sh
ol
d 
(°C
)
Co
ld
 p
ai
n 
th
re
sh
ol
d 
(°C
)
W
a
rm
 
de
te
ct
io
n 
th
re
sh
ol
d 
(°C
)
W
a
rm
 
de
te
ct
io
n 
th
re
sh
ol
d 
(°C
)
M
ec
ha
ni
ca
l p
ai
n 
th
re
sh
ol
d 
(g)
Vi
br
a
tio
n 
de
te
ct
io
n
th
re
sh
ol
d 
(μm
 s
e
co
n
ds
–
1 )
Vi
br
a
tio
n 
de
te
ct
io
n
th
re
sh
ol
d 
(μm
 s
e
co
n
ds
–
1 )
a b
dc
e f
g h Figure 2. Cryolipolysis reduces cutaneous sensitivity to mechanical and
thermal stimuli following cryolipolysis. Sensory threshold for Control side is
shown in white bars and Treatment side is shown in gray bars. (a and b)
Mechanical pain threshold (MPT); (c and d) Cold detection threshold (CDT);
(e and f) Vibration detection threshold (VDT); (g and h) Warmth detection
threshold (WDT). Data for each side are compared with baseline sensory
threshold. MPT data: bars represent median; whiskers represent LQ to UQ;
P-values were determined from Wilcoxon Signed Ranks Test. VDT, WDT, and
CDT data: bars represent mean; whiskers represent 95% CI; P-values were
determined from Mixed Model Repeated-Measures ANOVA with Bonferroni
correction (assuming signiﬁcance at Po0.05). Asterisks indicate the level of
signiﬁcance compared with Treatment baseline: *Po0.05; **Po0.01,
***Po0.005. Crosses (+) indicate the level of signiﬁcance compared with
Control baseline (+P=o0.05, +++P=o0.001). BL, Baseline.
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et al., 2005; Yosipovitch et al., 2007; Ishiuji et al., 2008).
When compared with the baseline value, there was signi-
ﬁcant, sustained reduction in histamine-induced itch duration
at 48–72 hrs, and days 14, 21, 35, and 56 after treatment, but
not compared with the control side (Supplementary Figure S1
and Supplementary Table S1 online). There was no signiﬁcant
change in mean or peak itch intensity after cryolipolysis
(Supplementary Table S2 and S3 online). The possible
Table 2. Mechanical and thermal sensory detection thresholds over the control and cryolipolyis-treated areas, with
pairwise comparisons for (1) side-tested and (2) post-treatment time1
Pairwise Comparisons
Side Time
QST Time Control Treatment Tx vs Control Control: vs BL Tx: vs BL
MDT (g)2
Baseline 0.43 (0.26–0.52) 0.40 (0.24–0.66) 0.35 (Z:–0.94) — —
48–72 h 0.40 (0.21–0.93) 0.87 (0.40–1.27) 0.18 (Z:–1.33) 0.65 (Z:–0.46) 0.07 (Z:–1.84)
Day 7 0.35 (0.20–0.67) 0.83 (0.45–1.30) 0.044 (Z:–2.07) 0.36 (Z:–0.92) 0.1 (Z:–1.63)
Day 14 0.33 (0.21–0.53) 0.47 (0.40–1.60) 0.15 (Z:–1.43) 0.42 (Z:–0.80) 0.33 (Z:–0.98)
Day 21 0.39 (0.24–0.60) 1.00 (0.40–1.13) 0.054 (Z:–1.99) 0.53 (Z:–0.62) 0.06 (Z:–1.91)
Day 35 0.32 (0.24–0.47) 0.47 (0.47–0.80) 0.18 (Z:–1.33) 0.36 (Z:–0.92) 0.24 (Z:–1.17)
Day 56 0.40 (0.24–0.47) 0.47 (0.32–0.47) 0.44 (Z:–0.77) 0.26 (Z:–1.13) 0.93 (Z:–0.09)
VDT (μm/sec)3
Baseline 17.6 (12.2–23.1) 17.8 (12.4–23.2) 0.93 — —
48–72 h 19.0 (13.6–24.4) 26.3 (20.9–31.7) o0.0014 0.42 o0.0014
Day 7 19.8 (14.4–25.3) 34.7 (29.3–40.2) o0.0014 0.2 o0.0014
Day 14 21.6 (16.2–27.0) 33.9 (28.5–39.4) o0.0014 0.02 o0.0014
Day 21 18.9 (14.5–25.3) 26.8 (21.4–32.3) o0.0014 0.18 o0.0014
Day 35 18.6 (13.2–24.0) 23.1 (17.7–28.5) o0.0014 0.57 0.01
Day 56 20.4 (15.0–25.9) 19.3 (13.8–24.7) 0.48 0.09 0.37
CDT (oC)3
Baseline 29.0 (27.6–30.3) 29.5 (28.1–30.8) 0.36 — —
48–72 h 29.6 (28.2–31.0) 26.2 (24.8–27.5) o0.0014 0.249 o0.0014
Day 7 29.2 (27.8–30.6) 28.6 (27.2–30.0) 0.23 0.63 0.1
Day 14 29.5 (28.1–30.1) 29.1 (27.7–30.5) 0.44 0.302 0.51
Day 21 29.8 (28.4–31.1) 28.7 (27.3–30.1) 0.05 0.137 0.16
Day 35 29.8 (28.4–31.2) 29.4 (28.0–30.8) 0.46 0.119 0.93
Day 56 29.7 (28.3–31.0) 29.9 (28.5–31.2) 0.69 0.193 0.44
WDT (oC)3
Baseline 34.5 (33.5–35.4) 34.7 (33.7–35.6) 0.365 — —
48–72 h 34.5 (33.5–35.4) 35.2 (34.3–36.2) o0.0014 0.98 0.014
Day 7 34.7 (33.8–35.7) 35.6 (34.6–36.5) o0.0014 0.24 o0.0014
Day 14 34.6 (33.7–35.5) 35.3 (34.4–36.2) 0.0014 0.62 0.0044
Day 21 34.5 (33.6–35.4) 35.3 (34.3–36.2) o0.0014 0.92 0.0064
Day 35 34.4 (33.4–35.2) 34.6 (33.7–35.5) 0.22 0.45 0.66
Day 56 34.1 (33.2–35.0) 34.6 (33.7–35.5) 0.02 0.08 0.67
Abbreviations: BL, Baseline; CDT, Cool Detection Threshold; MDT, Mechanical Detection Threshold; QST, Quantitative Sensory Testing; Tx, Treatment;
VDT, Vibration Detection Threshold; WDT, Warmth Detection Threshold.
1Mechanical detection using von Frey hairs and vibration is transmitted by myelinated Aβ afferent ﬁbers; cool detection is transmitted by myelinated Aδ and
unmyelinated C-ﬁbers; warmth detection is primarily transmitted by unmyelinated C-ﬁbers (Backonja et al., 2013).
2Median (25th to 75th percentile); P-values determined from Wilcoxon Signed Ranks Test.
3Mean (95% Conﬁdence Interval); P-values determined from Mixed Model Repeated-Measures ANOVA with Bonferroni correction (assuming signiﬁcance at
Po0.05). We observed that for some QST measures the differences were very small (i.e., o1oC) despite showing statistical signiﬁcance.
4Indicates statistically signiﬁcant differences.
Bold values denote signiﬁcant values.
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reduction of histamine-induced itch duration with cryolipo-
lysis could be an experimental artifact in light of the fact that
peak itch and mean itch intensity did not change, and further
studies are needed to substantiate the claim that cryolypolysis
is able to alter itch duration.
Itch and pain are distinct sensations, but they are closely
related with largely overlapping receptors and neuronal
subtypes. Unmyelinated C ﬁbers and thinly myelinated
A-delta ﬁbers are the primary sensory nerves that mediate
pain and itch sensation (Ikoma et al., 2006; Basbaum et al.,
2009). Histamine-sensitive itch nerves also respond to
noxious heat and/or to painful chemicals such as capsaicin,
making isolation of the nerves that transmit pain from those
that transmit histamine-induced itch experimentally impos-
sible in humans (Schmelz et al., 1997, 2003). In mice, Han
et al recently identiﬁed the existence of itch-speciﬁc
cutaneous nerves that express the MrgprA3 receptor (Han
et al., 2013). This distinct subset of sensory neurons that they
identiﬁed in mouse skin is crucial for itch induced by various
pruritogens but dispensable for acute and chronic pain (Han
et al., 2013). Itch-speciﬁc ﬁbers have yet to be identiﬁed in
human skin, although our data argue that such a population
may exist or at least that cryolipolysis selectively affects
nociceptors that respond only to pain, as opposed to those
more widely tuned to itch and pain. In our patients, we noted
that cryolipolysis induced speciﬁc loss of mechanical and
thermal pain sensation without altering the peak or mean itch
sensation. Because cryolipolysis did not affect itch but
reduced mechanical and thermal pain sensation, this techni-
que could potentially be used to study the subpopulation of
cutaneous C and A-delta ﬁbers that selectively responds to
itch in human skin. This would open new avenues for itch
research in understanding this population of neurons in
humans and developing targeted therapies.
Study limitations
QST was performed according to standardized instructions
and by the same experimenter (L.G) to ensure inter-
experimental reliability. Nevertheless, QST measures are
subjective, and they can be inﬂuenced by a range of physical
factors including experimental anxiety, attention, learning,
and environmental conditions. Subjects knew which ﬂank
was treated, and this knowledge may have affected their
sensory ratings. Thermal probes with a small surface area are
more sensitive at detecting sensory neuropathies, and it is
possible that we may be underestimating the changes in
thermal sensory threshold. With a large thermode, the
stimulus may inadvertently spread to neighboring receptive
ﬁelds; smaller thermodes are more sensitive for testing C-ﬁber-
mediated thresholds than larger ones because of the effects of
spatial summation (Hilz et al., 1999; Khalili et al., 2001).
Nevertheless, it is remarkable how changes in cutaneous
sensitivity seen over a 56-day period after cryolipolysis
treatment persist when compared with the baseline.
Clinical implications
Cryolipolysis is designed to target subcutaneous fat. Our study
shows that a single cycle of controlled sub-0 °C cold exposure
(cryolipolysis treatment) leads to prolonged hyposensitivity to
multiple sensory modalities. On the basis of these ﬁndings, if a
controlled cooling device could be optimized to selectively
target cutaneous nerves, it has the potential to provide long-
lasting relief of cutaneous pain, although further experiments
are required to clarify its ability to modulate itch. The optimal
Table 3. Histopathologic analysis of the cryolipolysis-
treated area over a 56-day period1
Time
Myelinated
Fibers/mm2 P-value ENF/mm2 P-value
Baseline 5.57 (4.12–7.02) — 8.96 (7.44–10.47) —
48-72 h 5.33 (3.88–6.78) 1 7.43 (5.91–8.94) 0.024*
Day 21 2.43 (0.98–3.88) o0.001* 6.45 (4.93–7.97) o0.001*
Day 56 2.74 (1.29–4.19) o0.001* 6.1 (4.59–7.62) o0.001*
Abbreviation: ENF-number of Epidermal Nerve Fiber.
1Mean (95% Conﬁdence Interval). Pairwise comparison of post-treatment
time point vs. baseline values determined from Repeated-Measures
ANOVA.
Bold values denote signiﬁcant values. BL
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Figure 3. Cryolipolysis reduces epidermal nerve ﬁber density and myelinated
dermal ﬁber density. (a) Density of epidermal nerve ﬁbers (ENF); (b) density of
myelinated dermal nerve ﬁbers. Data shown as mean (SD). P-values were
determined using mixed model repeated-measures ANOVA with Bonferroni
correction. Asterisks indicate the level of signiﬁcance compared with baseline.
*Po0.05.
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cooling parameters, treatment interval, and potential clinical
applications in dermatology remain to be established.
MATERIALS AND METHODS
Study design
This open-label, prospective, IRB-approved study was conducted
at the Massachusetts General Hospital (Boston) between December
2012 and July 2013, registered at ClinicalTrials.gov (NCT01673113)
(Figure 1), and it conforms to Declaration of Helsinki and Good
Clinical Practice Guidelines. Written, informed consent was obtained
from 11 healthy, adult subjects before participation, who were
randomized to receive a single cryolipolysis treatment on either the
left or right ﬂank. Sensory functions were evaluated using QST,
followed by histamine iontophoresis to evaluate itch duration on the
treated and control (untreated) ﬂank of each subject, before and at
48–72 hours, and Days 7, 14, 21, 35, and 56 post treatment. In 6
subjects, skin biopsies of the treated ﬂank were taken for analysis of
nerve ﬁber density at baseline, 48–72 hours, and Days 21 and 56
post treatment. Subjects were 18–65 years old, with visible adiposity
on both ﬂanks. Subjects with neurologic disorders, known cold
sensitivity, allergy or hypersensitivity to histamine, or dermatologic
condition in the area to be treated were excluded.
Cryolipolysis procedure
Cryolipolysis treatment was performed approximately 150 cm2 above
the iliac crest, on one side of the body. Cutaneous landmarks and
photographs were used to ensure that the same area was tested on
follow-up visits. Cryolipolysis was performed with EzApp6.3
applicator (Zeltiq Aesthetics, Pleasanton, CA) at a cooling intensity
factor of 41.6, corresponding to heat transfer of -73mW/cm2, for
1 hour. Immediately after treatment, all subjects had edema and
erythema and 6/11 subjects reported having pain in the treated area.
At 48–72 hours, 5/11 subjects still had mild erythema and only 2/11
subjects reported mild discomfort in the treated area. All subjects
(100%) were free of pain at Day 7 post treatment.
Quantitative sensory testing (QST)
QST evaluated mechanical (MDT), vibration (VDT), cool (CDT) and
warmth (WDT) detection threshold, and mechanical (MPT), cold
(CPT), and heat pain thresholds (HPT). Method of Limits approach
with stimuli of increasing intensity, starting at subthreshold levels,
was used. The QST protocol was performed in the following order:
Mechanical stimuli. MDT and MPT were evaluated ﬁrst, using von
Frey ﬁlaments (North Coast Medical, Gilroy, CA). The up-down
method, which evaluates the threshold force for appearance and
disappearance of a touch sensation reported by the subject, was used
until 3 values were obtained. MPT was determined by the minimum
force to elicit sharp “prick-like” pain sensation. VDT was evaluated
using a computerized vibrometer with 1cm2 contact probe placed
perpendicularly on the skin (TSA-II, Medoc Inc., Ramat Yishai, Israel).
This device gradually increased the vibration magnitude until the
subject pressed a “stop” button to indicate when they ﬁrst felt the
vibration. This test was repeated 8 times.
Thermal stimuli. Cool and warmth detection thresholds (CDT, WDT)
and cold and hot pain thresholds (CPT, HPT) were determined using a
3-cm2 Peltier thermal contact probe (TSA II, Medoc Inc., Ramat Yishai,
Israel). Starting from 32 °C, a stimulus ramp of 1.0 °C/s was used for
CDT and WDT, and 1.5 °C/s for CPT and HPT assessment. The subject
was asked to identify the sensations of warmth and cool, and hot and
cold, by pressing a “stop” button when each sensation was felt. CDT
and WDT were measured 4 times, and HPT and CPT was measured
3 times.
Histamine iontophoresis
A 20-mm2 iontophoresis electrode (Perimed, Stockholm, Sweden)
was used to deliver histamine base 1mg/ml (Histatrol ALK Abello,
Port Washington, NY) via a cathode current of 200 μA for 1 minute.
All subjects reported itch sensation at the end of iontophoresis.
Before iontophoresis, each subject was asked to rate their itch
intensity on a standardized visual analog scale (VAS) of 0 (no itch) to
10 (worst-itch). After iontophoresis, each subject was asked to
continue rating the itch intensity at 30-second intervals for a total of
10minutes. The duration of itch was calculated from the end of
iontophoresis to the complete resolution of itch. Erythema and wheal
diameters were measured 10min after iontophoresis.
Skin biopsy and immunohistochemistry
Skin biopsies (3 mm) were obtained, processed, and analyzed
according to consensus standards (Lauria et al., 2010). Tissue was
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Figure 4. Confocal microscopy imaging of biopsy samples. (a) A single biopsy
sample demonstrating the confocal imaging technique. The entire 3-mm skin
biopsy specimen with 70-μm thickness was imaged every 2 μm. Frames were
stacked to create a 3D projection of each confocal image. Thirty-ﬁve frames
per biopsy were generated and then stitched together using custom-built
routines in ImageJ/Fiji. (b) 3D projection of confocal image. The green channel
representing ﬁbers stained with anti-PGP9.5 was used to quantify epidermal
nerve ﬁbers, and the red channel representing ﬁbers stained with anti-MBP
antibody was used to quantify the dermal myelinated ﬁbers. Scale
bar=250 μm.
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placed in Zamboni’s ﬁxative (NewcommerSupply, Middleton, WI) for
24 hrs at room temperature, rinsed with 0.01M phosphate-buffered
saline (PBS), and placed in cryoprotectant (20% glycerol in 0.1M
Sorrenson’s phosphate buffer) for a minimum of 24 hrs at 4 °C. Serial
frozen sections of 70-μm thickness were made. Sections were
permeabilized in 0.5% Triton X-100 for 30minutes at room
temperature, incubated in TNB (0.1M Tris HCl, 0.15M NaCl, and
0.5% Boehringer milk powder) with 1% Triton X-100 for 2 hrs at
room temperature, and then treated overnight at 4 °C with
primary mouse antibodies against myelin basic protein (Calbiochem
Cat#NE1019-100ul, 1:1000) and anti-human PGP9.5 from
rabbits (ABDserotec Cat#7863-0504, 1:1000) diluted in TNB with
0.5% triton X-100. Sections were washed in 0.01M PBS with 0.5%
triton X-100 and ﬂuorescent secondary antibodies FITC-conjugated
donkey anti-rabbit and Cy3-conjugated donkey anti-mouse
(Jackson ImmunoResearch; 1:500) were applied for 2 hrs at room
temperature. Sections were washed in 0.01M PBS with 0.5% Triton
X-100, and then with 1mM CuSO4 for 10minutes, and mounted on
glass slides with VECTASHIELD Mounting Medium (Vector Labs,
Burlingame, CA).
Confocal microscopy and imaging
An Olympus Fluoview FV1000 laser scanning confocal microscope
with IX81 inverted microscope base was used, with 20X 0.75NA
(UPLSAPO) objective lens for imaging. An automated translation
stage with submicrometer accuracy was used for high-resolution,
large-area mosaic collection. Skin biopsy specimen sections were
imaged every 2 μm in depth at 512× 512 pixels per frame. Frames
were stacked to create a 3D projection of each confocal image.
Thirty-ﬁve frames per biopsy were generated and then stitched
together using custom-built routines developed in ImageJ/Fiji
(Schindelin et al., 2012). Multichannel z-stacks were then split and
every channel was projected to a single plane using a maximum
projection method. To analyze the whole captured mosaic, single
frames were stitched to form a single large image using a plugin
implemented previously (Preibisch et al., 2009) (Figure 4).
Epidermal Nerve Fiber Density (ENF) and dermal myelinated
nerve ﬁber density quantiﬁcation
The number of ENFs, and of dermal myelinated ﬁbers, was counted
using the ImageJ and NeuronJ software. The entire 3-mm skin biopsy
confocal image was quantiﬁed and two sections per biopsy were
analyzed per sample. ENF density was deﬁned as the number of
individual ﬁbers per mm of basement membrane, as they crossed the
dermal–epidermal junction; secondary branching within the
epidermis was excluded from the quantiﬁcation. Quantiﬁcation of
dermal myelinated ﬁbers was performed as previously described
(Doppler et al., 2012). Brieﬂy, the total number of individual
dermal myelinated ﬁbers per mm2 were counted by two
independent observers, one blinded and one unblinded to sample
identiﬁcation.
Statistical analysis
Sample size calculation. Calculations indicated over 80% power for
capturing treatment effects on QST, using F-Test ANOVA (version 7.0,
nQuery Advisor, Statistical Solutions, Saugus, MA). For biopsy analysis,
the sample size of six patients provided 80% power to detect a
minimum change of 30% at each time point using the F-test in repeated-
measures ANOVA, with one standard deviation changes from baseline
considered clinically signiﬁcant (Vittinghoff, 2005).
Statistics. Demographic data were reported as mean, standard
deviation; QST, histamine-iontophoresis, and histology were reported
as mean, 95% conﬁdence interval limits unless otherwise stated. All
data were tested for normality using the Kolmogorov–Smirnow good-
ness of ﬁt test. All outcome measures except mechanical QST (MDT
and MPT) followed a normal distribution. To test for differences in
sensitivity following cryolipolysis treatment, QST thresholds were
compared between (1) post-treatment versus baseline and (2) treated
area versus control, at all time points. A Mixed Model Repeated-
Measures ANOVA was used for QST data with a normal distribution; to
correct for multiple comparisons, two-tailed Po0.05 with Bonferroni
correction was considered signiﬁcant. A Wilcoxon signed-rank test was
used for nonparametric data (MDT and MPT). Histamine-induced itch
intensity and duration were analyzed using two-way repeated-measures
ANOVA. Histological results from skin punch biopsies, including
myelinated ﬁbers and ENF, were analyzed using a linear mixed model
repeated-measures ANOVA to account for four samples from the same
patient, assessed at the four different time points by two independent
observers, to account for the within-subject variability of the paired data
(treated and control ﬂanks) using a compound symmetry covariance
structure and the F-test to assess changes from baseline with a
Bonferroni adjusted P-value (Sahai and Ageel, 2000). To test inter-
observer agreement, the two observers were evaluated on each variable
and found to be comparable (Pearson r 40.80 for each variable). All
statistical analyses were performed with GraphPad Prism 5.04
(GraphPad Software Inc., CA), SPSS (IBM Corp., NY), or SAS v9.4
(SAS Institute).
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